Bio2040 - Bottlenecks & Future of Science, Healthcare & Biotech Flavio Rump

In Bio2040’s latest episode we had the chance to talk to Sam Lee, a long-time veteran of the biotech space. This episode covers some of the history and fundamentals of the synthetic biology and biomanufacturing space.

What are the main challenges in translating scientific innovation from the bench-side to the bedside? Physician and long-term Pharma executive Nadine Martin is now in charge of innovation management at sitem-insel AG. A translational unit of the Inselspital in Bern.

SEED2019 is a scrappy conference targeting innovation within the science publishing & funding process. It will bring together a diverse set of stakeholders and be followed by an incubator to implement the best ideas. We discuss problems and ideas on how to best solve the most pressing problems of academia.

How Open Source Drug Discovery can lower the risk and cost of drug discovery. M4K Pharma is pioneering a completely new model, where patents are not filed but data is shared. Yet they are still able to make money.

Peer review is opaque and a large frustration for many scientists. Preprints are becoming more prevalent, but we still need to assess them critically. We shed light on some of the problems and solutions to this with preprint peer review clubs. PREreview is a platform to record these journal club conversations so that the rest of the world can benefit from them too.

Oskari and Flavio talk about how robots can help humans in biomedical research. UniteLabs is building lab automation systems to automate boring tasks so the highly trained researchers can focus on more high-level activities. We also talk about other bottlenecks in biomedical research and revisit some old friends from previous podcast guests.